Infectious Hepatitis E Virus Genotype 3 Recombinants – Prospective Vaccine Candidates and Vector System | Office of Technology Transfer, NIH

Infectious Hepatitis E Virus Genotype 3 Recombinants – Prospective Vaccine Candidates and Vector System | Office of Technology Transfer, NIH

 Vaccine and Drug Development Opportunity:

Treatment and Prevention of Hepatitis E Virus

Electron micrograph of Hepatitis E viruses (HEV). Photo Credit: CDC



In recent years, there have been growing reports of Hepatitis E virus (HEV) infection in industrialized countries. Many of these infections are thought to be foodborne and caused by genotype 3 HEV. NIAID researchers have been able to adapt an isolated strain of genotype 3 HEV to grow in cell culture, which could potentially be used to develop vaccines and treatments for HEV. Read more about this exciting collaboration/licensing opportunity: https://www.ott.nih.gov/technology/e-074-2011

Follow NIAID Tech Transfer on LinkedIn.